In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The closing price of Amdocs Ltd (NASDAQ: DOX) was $76.91 for the day, down -0.58% from the previous closing price of $77.36. In other words, the price has decreased by -$0.58 from its previous closing price. On the day, 2.0 million shares were traded. DOX stock price reached its highest trading level at $77.28 during the session, while it also had its lowest trading level at $75.35.
Ratios:
Our analysis of DOX’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 26.03 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 13.11. For the most recent quarter (mrq), Quick Ratio is recorded 1.22 and its Current Ratio is at 1.17. In the meantime, Its Debt-to-Equity ratio is 0.24 whereas as Long-Term Debt/Eq ratio is at 0.23.
On October 02, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $100.Stifel initiated its Buy rating on October 02, 2024, with a $100 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Sep 02 ’25 when Raheja Rajat bought 2,285 shares for $85.50 per share.
Smith Matthew E. bought 525 shares of DOX for $46,063 on Feb 28 ’25.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DOX now has a Market Capitalization of 8383190528 and an Enterprise Value of 8947277824. As of this moment, Amdocs’s Price-to-Earnings (P/E) ratio for their current fiscal year is 15.16, and their Forward P/E ratio for the next fiscal year is 9.53. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.73. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.87 while its Price-to-Book (P/B) ratio in mrq is 2.41. Its current Enterprise Value per Revenue stands at 1.974 whereas that against EBITDA is 8.989.
Stock Price History:
The Beta on a monthly basis for DOX is 0.43, which has changed by -0.08418673 over the last 52 weeks, in comparison to a change of 0.1476624 over the same period for the S&P500. Over the past 52 weeks, DOX has reached a high of $95.41, while it has fallen to a 52-week low of $76.50. The 50-Day Moving Average of the stock is -7.55%, while the 200-Day Moving Average is calculated to be -11.86%.
Shares Statistics:
DOX traded an average of 915.64K shares per day over the past three months and 1339040 shares per day over the past ten days. A total of 109.99M shares are outstanding, with a floating share count of 109.41M. Insiders hold about 0.52% of the company’s shares, while institutions hold 96.95% stake in the company. Shares short for DOX as of 1761868800 were 5087053 with a Short Ratio of 5.56, compared to 1759190400 on 4577621. Therefore, it implies a Short% of Shares Outstanding of 5087053 and a Short% of Float of 5.6199998.
Dividends & Splits
With its trailing 12-month dividend rate of 2.06, DOX has a forward annual dividend rate of 2.06. Against a Trailing Annual Dividend Yield of 0.026628748. The stock’s 5-year Average Dividend Yield is 1.96.
Earnings Estimates
A detailed examination of Amdocs Ltd (DOX) is currently in progress, with 4.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is $1.81, with high estimates of $1.83 and low estimates of $1.79.
Analysts are recommending an EPS of between $7.68 and $7.4 for the fiscal current year, implying an average EPS of $7.49. EPS for the following year is $8.12, with 5.0 analysts recommending between $8.3 and $7.97.
Revenue Estimates
It is expected that $90B in revenue will be generated in. The current quarter, according to 4 analysts. It ranges from a high estimate of $1.17B to a low estimate of $1.15B. As of. The current estimate, Amdocs Ltd’s year-ago sales were $1.11BFor the next quarter, 4 analysts are estimating revenue of $1.17B. There is a high estimate of $1.17B for the next quarter, whereas the lowest estimate is $1.16B.
A total of 5 analysts have provided revenue estimates for DOX’s current fiscal year. The highest revenue estimate was $4.72B, while the lowest revenue estimate was $4.7B, resulting in an average revenue estimate of $4.7B. In the same quarter a year ago, actual revenue was $4.53BBased on 4 analysts’ estimates, the company’s revenue will be $4.91B in the next fiscal year. The high estimate is $4.98B and the low estimate is $4.87B.
